Literature DB >> 3893278

Marrow transplantation for thalassemia after treatment with busulfan and cyclophosphamide.

G Lucarelli, P Polchi, T Izzi, M Manna, C Delfini, M Galimberti, A Porcellini, L Moretti, A Manna, G Sparaventi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3893278     DOI： 10.1111/j.1749-6632.1985.tb17212.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Defining the intensity of conditioning regimens: working definitions.

Authors:  Andrea Bacigalupo; Karen Ballen; Doug Rizzo; Sergio Giralt; Hillard Lazarus; Vincent Ho; Jane Apperley; Shimon Slavin; Marcelo Pasquini; Brenda M Sandmaier; John Barrett; Didier Blaise; Robert Lowski; Mary Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-01       Impact factor: 5.742

2.  Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation.

Authors:  Sang-Heon Cho; Jung-Hee Lee; Hyeong-Seok Lim; Kyoo-Hyung Lee; Dae-Young Kim; Sangmin Choe; Kyun-Seop Bae; Je-Hwan Lee
Journal:  Korean J Physiol Pharmacol       Date:  2016-04-26       Impact factor: 2.016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.